Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing
Launched by CAPITAL MEDICAL UNIVERSITY · Jul 3, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding better ways to help children and teenagers in Beijing who are dealing with depression and obesity. These two issues often occur together and can significantly affect a young person's health. The researchers want to create a comprehensive plan that combines different strategies to prevent and treat both conditions at the same time. They will be using a digital platform to reach students and their families, making it easier for them to access support and resources.
To be part of this study, students must be middle schoolers living in specific areas of Beijing, and they or their guardians need to agree to participate by signing a consent form. The trial will first screen students to find those at high risk for depression (with a specific score on a depression checklist) and obesity (based on their weight compared to their height). Participants will receive support tailored to their needs, and the aim is to create a model that can be used in other places to help more young people across the country. This research is part of a larger effort to improve health for children and adolescents in China by 2030.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Stage I (screening stage):
- • 1. Middle school students in Beijing Economic-Technological Development Area and other districts of Beijing, both male and female;
- • 2. Students themselves and their guardians are willing to participate in this study and sign written informed consent file.
- Stage Ⅱ:
- Middle school students who were identified as high risk of depression and/or obesity in Stage I in Beijing Economic-Technological Development Area and other districts of Beijing, the screening criteria are as follows:
- • ① CES-DC score ≥16 points;
- • ② BMI ≥WS/T586-2018: Screened as overweight and obesity among school-age children and adolescents, according to the recommendation by the National Health Commission;
- • ③ Students themselves and their guardians are willing to participate in this study and provide written informed consent.
- Exclusion Criteria:
- * Stage I:
- • 1. Having serious physical or genetic disease that is not suitable for participation in the study;
- • 2. Have been evaluated that not suitable for this study by investigators.
- Stage Ⅱ:
- • 1. Having serious physical or genetic disease that is not suitable for participation in the study;
- • 2. Have been evaluated that not suitable for this study by investigators.
About Capital Medical University
Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported